Published in J Bone Miner Res on July 01, 2009
Meta-analysis: excess mortality after hip fracture among older women and men. Ann Intern Med (2010) 4.24
Declining incidence of hip fractures and the extent of use of anti-osteoporotic therapy in Denmark 1997-2006. Osteoporos Int (2009) 1.33
Osteoporosis, frailty and fracture: implications for case finding and therapy. Nat Rev Rheumatol (2012) 1.28
Hip fracture epidemiological trends, outcomes, and risk factors, 1970-2009. Int J Gen Med (2010) 1.22
Risk of subsequent fracture and mortality within 5 years after a non-vertebral fracture. Osteoporos Int (2010) 1.18
Adherence and profile of non-persistence in patients treated for osteoporosis--a large-scale, long-term retrospective study in The Netherlands. Osteoporos Int (2010) 1.05
Assessment of individual fracture risk: FRAX and beyond. Curr Osteoporos Rep (2010) 1.01
Implementation of osteoporosis guidelines: a survey of five large fracture liaison services in the Netherlands. Osteoporos Int (2010) 1.00
Hip fractures in Norway 1999-2008: time trends in total incidence and second hip fracture rates: a NOREPOS study. Eur J Epidemiol (2012) 0.97
Dynamic skeletal muscle stimulation and its potential in bone adaptation. J Musculoskelet Neuronal Interact (2010) 0.96
A health economic analysis of osteoporotic fractures: who carries the burden? Arch Osteoporos (2013) 0.88
Postoperative blood transfusion strategy in frail, anemic elderly patients with hip fracture: the TRIFE randomized controlled trial. Acta Orthop (2015) 0.85
Cemented Thompson's hemiarthroplasty in patients with intracapsular neck of femur fractures: survival analysis of 1,670 procedures. Eur J Orthop Surg Traumatol (2014) 0.85
Diagnosis and treatment of osteoporosis before and after admission to long-term care institutions. Osteoporos Int (2011) 0.85
Parameters Pointing at an Increased Risk for Contralateral Hip Fractures: Systematic Review. Geriatr Orthop Surg Rehabil (2016) 0.84
Can Hip Fracture Prediction in Women be Estimated beyond Bone Mineral Density Measurement Alone? Ther Adv Musculoskelet Dis (2010) 0.84
Osteosynthetic improvement of osteoporotic bone: prevention surgery. Clin Cases Miner Bone Metab (2011) 0.83
Constructing an episode of care from acute hospitalization records for studying effects of timing of hip fracture surgery. J Orthop Res (2015) 0.83
The second hip fracture in osteoporotic patients: not only an orthopaedic matter. Clin Cases Miner Bone Metab (2013) 0.82
Linked versus unlinked hospital discharge data on hip fractures for estimating incidence and comorbidity profiles. BMC Med Res Methodol (2012) 0.82
The risk of major and any (non-hip) fragility fracture after hip fracture in the United Kingdom: 2000-2010. Osteoporos Int (2014) 0.82
The incidence of hip fractures in Estonia, 2005-2012. Osteoporos Int (2014) 0.82
Subsequent fracture rates in a nationwide population-based cohort study with a 10-year perspective. Osteoporos Int (2014) 0.81
Patterns of Prescription Drug Use Before and After Fragility Fracture. JAMA Intern Med (2016) 0.81
Excess mortality associated with second hip fracture. Osteoporos Int (2015) 0.81
Epidemiology of forearm fractures in adults in Denmark: national age- and gender-specific incidence rates, ratio of forearm to hip fractures, and extent of surgical fracture repair in inpatients and outpatients. Osteoporos Int (2014) 0.81
Changes in first hip fracture rates in British Columbia Canada, 1990-2004. Osteoporos Int (2011) 0.80
Subsequent hip fracture in osteoporotic hip fracture patients. Yonsei Med J (2012) 0.79
Using vital statistics to estimate the population-level impact of osteoporotic fractures on mortality based on death certificates, with an application to France (2000-2004). BMC Public Health (2009) 0.79
Antiresorptive therapy and risk of mortality and refracture in osteoporosis-related hip fracture: a nationwide study. Osteoporos Int (2015) 0.79
Cost-effectiveness analysis of hip fracture prevention with vitamin D supplementation: a Markov micro-simulation model applied to the French population over 65 years old without previous hip fracture. Osteoporos Int (2014) 0.79
Timing of subsequent fractures after an initial fracture. Curr Osteoporos Rep (2010) 0.78
Identification and management of patients at increased risk of osteoporotic fracture: outcomes of an ESCEO expert consensus meeting. Osteoporos Int (2017) 0.78
Zoledronic Acid for the treatment and prevention of primary and secondary osteoporosis. Ther Adv Musculoskelet Dis (2010) 0.78
Risk factors for peripheral fractures vary by age in older men--the prospective MINOS study. Osteoporos Int (2010) 0.78
Cumulative incidence and treatment of non-simultaneous bilateral femoral neck fractures in a cohort of one thousand two hundred and fifty patients. Int Orthop (2014) 0.78
The role of the combination of bone and fall related risk factors on short-term subsequent fracture risk and mortality. BMC Musculoskelet Disord (2013) 0.77
Fragility fracture prevention: review from a Japanese perspective. Yonago Acta Med (2012) 0.77
Imminent fracture risk. Osteoporos Int (2017) 0.76
Accuracy of evidence-based criteria for identifying an incident hip fracture in the absence of the date of injury: a retrospective database study. BMJ Open (2013) 0.76
Unmet needs and current and future approaches for osteoporotic patients at high risk of hip fracture. Arch Osteoporos (2016) 0.76
The burden of second hip fractures: provincial surgical hospitalizations over 15 years. Can J Surg (2017) 0.75
Expert Consensus on Predictive Parameters for the Occurrence of a Fall and a Contralateral Hip Fracture 1 and 3 Years After Hip Fracture: A Delphi Survey. Geriatr Orthop Surg Rehabil (2017) 0.75
Non-steroidal anti-inflammatory drugs and the risk of a second hip fracture: a propensity-score matching study. BMC Musculoskelet Disord (2016) 0.75
Percutaneous internal fixation with Y-STRUT® device to prevent both osteoporotic and pathological hip fractures: a prospective pilot study. J Orthop Surg Res (2017) 0.75
Chronic NSAIDs Use Increases the Risk of a Second Hip Fracture in Patients After Hip Fracture Surgery: Evidence From a STROBE-Compliant Population-Based Study. Medicine (Baltimore) (2015) 0.75
Improving hip fracture care in ireland: a preliminary report of the irish hip fracture database. J Osteoporos (2014) 0.75
A model for time to fracture with a shock stream superimposed on progressive degradation: the Study of Osteoporotic Fractures. Stat Med (2014) 0.75
The future is physio …. Physiother Can (2011) 0.75
Incidence, Morbidity and Mortality in Patients Older than 50 Years with Second Hip Fracture in a Jeju Cohort Study. Hip Pelvis (2014) 0.75
Prophylactic augmentation of the osteoporotic proximal femur-mission impossible? Bonekey Rep (2016) 0.75
Imminent risk of fracture after fracture. Osteoporos Int (2016) 0.75
BFH-OSTM, a new predictive screening tool for identifying osteoporosis in elderly Han Chinese males. Clin Interv Aging (2017) 0.75
Rehabilitation Practitioners' Prioritized Care Processes in Hip Fracture Post-Acute Care. Phys Occup Ther Geriatr (2017) 0.75
Hip fracture registries: utility, description, and comparison. Osteoporos Int (2016) 0.75
Subjects with osteoporosis to remain at high risk for fracture despite benefit of prior bisphosphonate treatment-a Danish case-control study. Osteoporos Int (2016) 0.75
Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial. BMJ (2012) 5.63
Fracture risk and zoledronic acid therapy in men with osteoporosis. N Engl J Med (2012) 3.51
Overweight and obesity as risk factors for atrial fibrillation or flutter: the Danish Diet, Cancer, and Health Study. Am J Med (2005) 2.84
Large-scale analysis of association between LRP5 and LRP6 variants and osteoporosis. JAMA (2008) 2.52
The effects of calcium supplementation on verified coronary heart disease hospitalization and death in postmenopausal women: a collaborative meta-analysis of randomized controlled trials. J Bone Miner Res (2015) 2.49
Hypoparathyroidism in the adult: epidemiology, diagnosis, pathophysiology, target-organ involvement, treatment, and challenges for future research. J Bone Miner Res (2011) 2.30
Caffeine and risk of atrial fibrillation or flutter: the Danish Diet, Cancer, and Health Study. Am J Clin Nutr (2005) 2.07
HIV infection is strongly associated with hip fracture risk, independently of age, gender, and comorbidities: a population-based cohort study. J Bone Miner Res (2013) 1.84
Differing effects of PTH 1-34, PTH 1-84, and zoledronic acid on bone microarchitecture and estimated strength in postmenopausal women with osteoporosis: an 18-month open-labeled observational study using HR-pQCT. J Bone Miner Res (2013) 1.78
Timing of acute myocardial infarction in patients undergoing total hip or knee replacement: a nationwide cohort study. Arch Intern Med (2012) 1.66
Changes in mortality patterns following total hip or knee arthroplasty over the past two decades: a nationwide cohort study. Arthritis Rheumatol (2014) 1.61
Fracture risk associated with use of antiepileptic drugs. Epilepsia (2004) 1.55
Changes in 3-dimensional bone structure indices in hypoparathyroid patients treated with PTH(1-84): a randomized controlled study. J Bone Miner Res (2012) 1.54
Effects of long-term strontium ranelate treatment on the risk of nonvertebral and vertebral fractures in postmenopausal osteoporosis: Results of a five-year, randomized, placebo-controlled trial. Arthritis Rheum (2008) 1.51
High-dose treatment with vitamin A analogues and risk of fractures. Arch Dermatol (2010) 1.50
Treatment with beta-blockers, ACE inhibitors, and calcium-channel blockers is associated with a reduced fracture risk: a nationwide case-control study. J Hypertens (2006) 1.48
Chronic diseases in elderly men: underreporting and underdiagnosis. Age Ageing (2011) 1.48
Alcohol and risk of atrial fibrillation or flutter: a cohort study. Arch Intern Med (2004) 1.48
The relationship between health-related quality of life, obesity and testosterone levels in older men. Age Ageing (2013) 1.47
Fracture risk in users of oral anticoagulants: a nationwide case-control study. Int J Cardiol (2006) 1.46
Osteoporosis is markedly underdiagnosed: a nationwide study from Denmark. Osteoporos Int (2004) 1.43
Vitamin D with calcium reduces mortality: patient level pooled analysis of 70,528 patients from eight major vitamin D trials. J Clin Endocrinol Metab (2012) 1.42
The effect of adding PTH(1-84) to conventional treatment of hypoparathyroidism: a randomized, placebo-controlled study. J Bone Miner Res (2011) 1.42
Diabetes and its complications and their relationship with risk of fractures in type 1 and 2 diabetes. Calcif Tissue Int (2008) 1.40
[Denosumab--a new efficient osteoporosis therapy]. Ugeskr Laeger (2011) 1.39
Risk assessment tools to identify women with increased risk of osteoporotic fracture: complexity or simplicity? A systematic review. J Bone Miner Res (2013) 1.38
Current issues in the presentation of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop. J Clin Endocrinol Metab (2014) 1.35
Relationship between bone mineral density changes and fracture risk reduction in patients treated with strontium ranelate. J Clin Endocrinol Metab (2007) 1.32
Discriminative power of three indices of renal calcium excretion for the distinction between familial hypocalciuric hypercalcaemia and primary hyperparathyroidism: a follow-up study on methods. Clin Endocrinol (Oxf) (2008) 1.31
Fractures in patients with anorexia nervosa, bulimia nervosa, and other eating disorders--a nationwide register study. Int J Eat Disord (2002) 1.27
Trend in mortality after stroke with atrial fibrillation. Am J Med (2007) 1.26
Strontium ranelate reduces the risk of vertebral and nonvertebral fractures in women eighty years of age and older. J Bone Miner Res (2006) 1.24
Nephrolithiasis and renal calcifications in primary hyperparathyroidism. J Clin Endocrinol Metab (2011) 1.24
Suppression of endogenous testosterone production attenuates the response to strength training: a randomized, placebo-controlled, and blinded intervention study. Am J Physiol Endocrinol Metab (2006) 1.24
Patient education in groups increases knowledge of osteoporosis and adherence to treatment: a two-year randomized controlled trial. Patient Educ Couns (2010) 1.22
The risk of fracture in patients with multiple sclerosis: the UK general practice research database. J Bone Miner Res (2011) 1.22
Gastric and esophagus events before and during treatment of osteoporosis. Calcif Tissue Int (2009) 1.22
Fracture risk associated with parkinsonism and anti-Parkinson drugs. Calcif Tissue Int (2007) 1.22
Visceral and subcutaneous adipose tissue assessed by magnetic resonance imaging in relation to circulating androgens, sex hormone-binding globulin, and luteinizing hormone in young men. J Clin Endocrinol Metab (2007) 1.21
Hypertension is a risk factor for fractures. Calcif Tissue Int (2008) 1.19
Hyperthyroidism and risk of atrial fibrillation or flutter: a population-based study. Arch Intern Med (2004) 1.18
Risk of renal stone events in primary hyperparathyroidism before and after parathyroid surgery: controlled retrospective follow up study. BMJ (2002) 1.17
Has mortality after a hip fracture increased? J Am Geriatr Soc (2007) 1.16
Sequential treatment of severe postmenopausal osteoporosis after teriparatide: final results of the randomized, controlled European Study of Forsteo (EUROFORS). J Bone Miner Res (2009) 1.16
Autosomal dominant osteopetrosis revisited: lessons from recent studies. Eur J Endocrinol (2013) 1.12
Selective serotonin reuptake inhibitors and other antidepressants and risk of fracture. Calcif Tissue Int (2008) 1.10
Increased plasma concentrations of vitamin D metabolites and vitamin D binding protein in women using hormonal contraceptives: a cross-sectional study. Nutrients (2013) 1.09
n-3 Fatty acids consumed from fish and risk of atrial fibrillation or flutter: the Danish Diet, Cancer, and Health Study. Am J Clin Nutr (2005) 1.09
Effects on bone geometry, density, and microarchitecture in the distal radius but not the tibia in women with primary hyperparathyroidism: A case-control study using HR-pQCT. J Bone Miner Res (2010) 1.08
Levels of serotonin, sclerostin, bone turnover markers as well as bone density and microarchitecture in patients with high-bone-mass phenotype due to a mutation in Lrp5. J Bone Miner Res (2011) 1.06
[Medical therapy of osteoporosis in patients with mildly to moderate decreased renal function]. Ugeskr Laeger (2012) 1.06
PTH(1-84) replacement therapy in hypoparathyroidism: a randomized controlled trial on pharmacokinetic and dynamic effects after 6 months of treatment. J Bone Miner Res (2013) 1.06
A randomized trial of laypersons' perception of the benefit of osteoporosis therapy: number needed to treat versus postponement of hip fracture. Clin Ther (2003) 1.06
Intake of vitamin D and risk of breast cancer--a meta-analysis. J Steroid Biochem Mol Biol (2008) 1.06
Smoking as a risk factor for Graves' disease, toxic nodular goiter, and autoimmune hypothyroidism. Thyroid (2002) 1.05
Birth prevalence and mutation spectrum in danish patients with autosomal recessive albinism. Invest Ophthalmol Vis Sci (2008) 1.05
Use of insulin and insulin analogs and risk of cancer - systematic review and meta-analysis of observational studies. Curr Drug Saf (2013) 1.05
Trends in incidence and mortality in the hospital diagnosis of atrial fibrillation or flutter in Denmark, 1980-1999. Int J Cardiol (2005) 1.04
Incidence of fractures in patients with multiple sclerosis: the Danish National Health Registers. Mult Scler (2011) 1.03
Loop diuretics increase bone turnover and decrease BMD in osteopenic postmenopausal women: results from a randomized controlled study with bumetanide. J Bone Miner Res (2005) 1.03
Effects of simvastatin on bone turnover and BMD: a 1-year randomized controlled trial in postmenopausal osteopenic women. J Bone Miner Res (2004) 1.03
Allogeneic blood transfusion and prognosis following total hip replacement: a population-based follow up study. BMC Musculoskelet Disord (2009) 1.02
Osteoarthritis and risk of fractures. Calcif Tissue Int (2009) 1.02
Reduced prediagnostic 25-hydroxyvitamin D levels in women with breast cancer: a nested case-control study. Cancer Epidemiol Biomarkers Prev (2009) 1.01
Incidence and prevalence of nutritional and hereditary rickets in southern Denmark. Eur J Endocrinol (2008) 1.00
Fracture risk in Danish men with prostate cancer: a nationwide register study. BJU Int (2007) 0.99
Postsurgical hypoparathyroidism--risk of fractures, psychiatric diseases, cancer, cataract, and infections. J Bone Miner Res (2014) 0.99
HIV infection and its association with an excess risk of clinical fractures: a nationwide case-control study. J Acquir Immune Defic Syndr (2014) 0.99
Hip fracture risk in statin users--a population-based Danish case-control study. Osteoporos Int (2004) 0.99
Vitamin D treatment in primary hyperparathyroidism: a randomized placebo controlled trial. J Clin Endocrinol Metab (2014) 0.98
Use of metformin and survival of diabetic women with breast cancer. Curr Drug Saf (2013) 0.98
Decreased fracture risk in users of organic nitrates: a nationwide case-control study. J Bone Miner Res (2006) 0.98
Patients with high-bone-mass phenotype owing to Lrp5-T253I mutation have low plasma levels of serotonin. J Bone Miner Res (2010) 0.98
Single-nucleotide polymorphisms in the P2X7 receptor gene are associated with post-menopausal bone loss and vertebral fractures. Eur J Hum Genet (2012) 0.98
Determinants of plasma PTH and their implication for defining a reference interval. Clin Endocrinol (Oxf) (2011) 0.97
Fracture risk in perimenopausal women treated with beta-blockers. Calcif Tissue Int (2004) 0.96
Simvastatin does not affect vitamin d status, but low vitamin d levels are associated with dyslipidemia: results from a randomised, controlled trial. Int J Endocrinol (2009) 0.96
Are antiresorptive drugs effective against fractures in patients with diabetes? Calcif Tissue Int (2010) 0.95
Bone microarchitecture and estimated strength in 499 adult Danish women and men: a cross-sectional, population-based high-resolution peripheral quantitative computed tomographic study on peak bone structure. Calcif Tissue Int (2013) 0.94
Molecular genetic analysis of the calcium sensing receptor gene in patients clinically suspected to have familial hypocalciuric hypercalcemia: phenotypic variation and mutation spectrum in a Danish population. J Clin Endocrinol Metab (2007) 0.94
The effects of depot medroxyprogesterone acetate and intrauterine device use on fracture risk in Danish women. Contraception (2008) 0.94
Gender differences in outcome of eating disorders: a retrospective cohort study. Psychiatry Res (2010) 0.94
Cardiovascular and renal complications to postsurgical hypoparathyroidism: a Danish nationwide controlled historic follow-up study. J Bone Miner Res (2013) 0.93
Parathyroidectomy improves bone geometry and microarchitecture in female patients with primary hyperparathyroidism: a one-year prospective controlled study using high-resolution peripheral quantitative computed tomography. J Bone Miner Res (2012) 0.93
Effect of tamoxifen and aromatase inhibitors on the risk of fractures in women with breast cancer. Calcif Tissue Int (2008) 0.93
Familial hypocalciuric hypercalcaemia: a review. Curr Opin Endocrinol Diabetes Obes (2011) 0.93
Assessment of the global trigger tool to measure, monitor and evaluate patient safety in cancer patients: reliability concerns are raised. BMJ Qual Saf (2013) 0.93
Testosterone therapy increased muscle mass and lipid oxidation in aging men. Age (Dordr) (2011) 0.93
Strontium ranelate reduces the risk of vertebral fractures in patients with osteopenia. J Bone Miner Res (2008) 0.92
Geographical variation in DXA bone mineral density in young European men and women. Results from the Network in Europe on Male Osteoporosis (NEMO) study. Bone (2008) 0.91
Trends in risk of stroke in patients with a hospital diagnosis of nonvalvular atrial fibrillation: National Cohort Study in Denmark, 1980-2002. Neuroepidemiology (2006) 0.91
Emerging anabolic treatments in osteoporosis. Curr Drug Saf (2011) 0.91
Back pain during different sequential treatment regimens of teriparatide: results from EUROFORS. Curr Med Res Opin (2010) 0.91
Mutational analysis of PHEX, FGF23, DMP1, SLC34A3 and CLCN5 in patients with hypophosphatemic rickets. J Hum Genet (2012) 0.91
Fracture risk in patients with chronic lung diseases treated with bronchodilator drugs and inhaled and oral corticosteroids. Chest (2007) 0.90